Grants / Department of Health and Human Services / Centers for Disease Control and Prevention - ERA

RFA-DP-22-001: Real-world effectiveness of structured lifestyle interventions in preventing type 2 diabetes

Closed Closed February 1, 2022 Opportunity RFA-DP-22-001 ☆ Save

This grant is closed. A newer notice from the same program is open now: NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) (PA-27-100). Status: Due dates in the notice, expires April 5, 2027. It is in our archive of Centers for Disease Control and Prevention - ERA notices from 2021.

• Award ceiling$570,000
• Total funding$16.0 million
• Expected awards6
• Cost sharingNot required
• Funding typeCooperative Agreement

Key dates

Who can apply

This opportunity was open to any type of organization.

For an applicant to be even considered they must be responsive to the following. Component A - Longitudinal Cohort: Applicants must provide evidence of being able to access electronic records for building a cohort of individuals meeting eligibility criteria for the NDPP/MDPP (both participated in the NDPP/MDPP and not participated but eligible for the NDPP/MDPP program), individual program participation information of the NDPP/MDPP participants, medical records and health services utilization and cost data of all study participants. A minimum number of 5,000 NDPP/MDPP program enrollees and equal or a greater number of matched controls is required per applicant. If the application is incomplete or non-responsive to the special eligibility requirements listed in this section, it will not enter into the review process. Component B - Coordinating Center: Not Applicable

More grants for nonprofits, colleges and universities, state and local governments, tribes, small businesses, businesses, individuals.

Is this a realistic fit?

• Past Chronic Diseases: Research, Control, and Prevention awards averaged $651,162; this notice allows up to $570,000 per award.
• Most of the program's money (35% over five years) went to nonprofits.
• No cost sharing or match is required.

What the grant funds

The purpose of this Notice of Funding Opportunity Announcement (NOFO) is to assess the long-term effectiveness, cost-effectiveness, and barriers to enrollment in or completion of structured lifestyle interventions (SLI), as implemented by the National Diabetes Prevention Program (NDPP). This NOFO has two (2) components to achieve the purpose of the program: Component A: To evaluate the long-term (≥5 years) effectiveness and cost-effectiveness of SLI participants, and identify barriers to participation and adherence in these SLI programs, overall and by age group, sex, race/ethnicity, and socio-economic status. The study participants are those who meet the NDPP eligibility criteria and completed the NDPP curriculum. The study will also include a control group consisting of individuals who meet the NDPP eligibility criteria but are either not enrolled in the SLI program or do not complete it. Applicants shall connect individual level data from SLI program providers, electronic health records and claims with follow up information on the study participants for a minimum of 5 years. The study shall include SLI delivered in person, virtually, and a combination of the two. Component B: The Coordinating Center provides the infrastructure for data storage (if needed), harmonizing data collection and data analysis, logistic and communication support to enhance the efficiency, productivity for component A.

Category: Health.

Applying now

This notice no longer takes applications. Apply under the newer notice, PA-27-100, which is open now.

The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.